BNP Paribas Financial Markets’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.23M | Sell |
|
|||||
|
2025
Q2 | $1.11M | Buy |
|
|||||
|
2025
Q1 | $893K | Sell |
|
|||||
|
2024
Q4 | $1.99M | Buy |
|
|||||
|
2024
Q3 | $720K | Buy |
|
|||||
|
2024
Q2 | $238K | Sell |
|
|||||
|
2024
Q1 | $1.15M | Sell |
|
|||||
|
2023
Q4 | $2.6M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Buy |
|
|||||
|
2023
Q2 | $1M | Sell |
|
|||||
|
2023
Q1 | $2.04M | Buy |
|
|||||
|
2022
Q4 | $1.12M | Sell |
|
|||||
|
2022
Q3 | $2.95M | Buy |
|
|||||
|
2022
Q2 | $239K | Sell |
|
|||||
|
2022
Q1 | $986K | Buy |
|
|||||
|
2021
Q4 | $1.02M | Buy |
|
|||||
|
2021
Q3 | $286K | Sell |
|
|||||
|
2021
Q2 | $5.36M | Buy |
|
|||||
|
2021
Q1 | $405K | Buy |
|
|||||
|
2020
Q4 | $292K | Sell |
|
|||||
|
2020
Q3 | $195K | Buy |
|
|||||
|
2020
Q2 | $71.9K | Sell |
|
|||||
|
2020
Q1 | $173K | Buy |
|
|||||
|
2019
Q4 | $78.6K | Sell |
|
|||||
|
2019
Q3 | $47.7K | Buy |
|
|||||
|
2019
Q2 | $39.7K | Sell |
|
|||||
|
2019
Q1 | $86.6K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $16.8K | Sell |
|
|||||
|
2018
Q2 | $15.1K | Buy |
|
|||||
|
2018
Q1 | $19 | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $7 | Hold |
|
|||||
|
2017
Q2 | $8 | Sell |
|
|||||
|
2017
Q1 | $204 | Sell |
|
|||||
|
2016
Q4 | $6K | Sell |
|
|||||
|
2016
Q3 | $11.3K | Buy |
|
|||||
|
2016
Q2 | $5.13K | Buy |
|